SDI Stock

SDI EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of SDI (SDI.AX) as of Jul 22, 2026 is 6.73. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 5.82 — a change of 15.72% (higher).

EV/EBIT

6.73

YoY

15.72%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of SDI is 2026 6.73 . EV/EBIT (Enterprise Value to EBIT) of SDI was 2025 5.82 . It decreases by 15.72% higher compared to the previous year.

The SDI EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
9.45 base
Jan 1, 2020
18.37 base
Jan 1, 2021
9.30 base
Jan 1, 2022
10.96 base
Jan 1, 2023
8.27 base
Jan 1, 2024
7.48 base
Jan 1, 2025
6.88 base
Jan 1, 2026 (e)
9.14 base
YEARPRICE-TO-EBIT
2026 est 9.14
2025 6.88
2024 7.48
2023 8.27
2022 10.96
2021 9.30
2020 18.37
2019 9.45
2018 9.40
2017 8.56
2016 7.80
2015 7.45
2014 9.11
2013 15.04
2012 9.13
2011 5.81
2010 5.88
2009 13.31
2008 24.48
2007 7.92
2006 13.89
Access this data via the Eulerpool API

SDI Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides SDI's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates SDI's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots SDI's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if SDI grows earnings faster than its peers.

SDI Stock analysis

What does SDI do? SDI Ltd is a British company specializing in the development and manufacture of scientific and medical devices. The company was founded by John Poulter in 1952 and is headquartered in Basingstoke, Hampshire. The history of SDI Ltd began with the development of scientific measuring devices, particularly instruments for measuring optical signals. Over the years, the company has specialized in the development of devices for medical diagnostics and therapy. SDI Ltd now operates in various areas. One of its main business fields is microbiology and infection prevention. The company offers a wide range of products including test systems for infectious diseases such as HIV, Hepatitis B and C, tuberculosis, and malaria. Another business field of SDI Ltd is the development of devices for the diagnosis of cancer and other diseases. The company offers both instruments for tissue sampling as well as automated diagnostic systems. SDI Ltd is also active in medical technology and offers a wide range of products, from simple instruments like thermal thermometers to complex surgical instruments and implants. In addition to medical diagnostics and therapy, SDI Ltd is also active in the field of analytical technology. The company offers instruments for chemical analysis, environmental monitoring, and food sampling. The business model of SDI Ltd is based on the development and manufacture of high-quality and reliable devices for scientific, medical, and industrial use. The company relies on close collaboration with customers and partners to provide innovative solutions for the challenges of modern science and medicine. An important part of SDI Ltd's business model is research and development. The company invests a significant portion of its revenue in the development of new products and technologies to always offer its customers the latest and best solutions. Overall, SDI Ltd has established itself as a leading company in the field of scientific and medical devices. The company has a long history of successful product developments and is known for its high quality, reliability, and innovation. With its wide range of products and its commitment to research and development, SDI Ltd is well-equipped to continue playing an important role in science and medicine in the future. SDI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SDI stock

EV/EBIT (Enterprise Value to EBIT) of SDI is 6.73 in 2026.

Access this data via the Eulerpool API

Valuation — SDI

All Key Metrics — SDI